Business, energy, technology, markets and global industry news from Business News Today

Ministry of Food and Drug Safety

PharmaDeviceNews Ministry of Food and Drug Safety
Huonslab’s new patent targets subcutaneous antibody-drug conjugate formulations using its HyDIFFUZE platform, highlighting the growing race to make complex oncology therapies easier and faster to administer. Representative image.
Pharma & Biotech

Can Huonslab crack oncology’s next drug-delivery problem? New patent targets injectable ADCs

Huonslab’s HyDIFFUZE patent targets subcutaneous ADC formulations, but preclinical evidence and clinical translation remain the real test.

Read More
Neuronata-R’s continued conditional approval in South Korea shifts attention to CorestemChemon’s planned ALS stem cell therapy manufacturing restart in 2027. Representative image.
Pharma & Biotech

South Korea kept Neuronata-R on the market. Now CorestemChemon’s harder test begins

South Korea keeps Neuronata-R available after Phase 3 review, but manufacturing, patient selection and a delayed U.S. filing remain decisive tests ahead.

Read More